CARDIOVASCULAR DISEASE IN SPECIAL POPULATIONS
Professor T. Suter (Bern, CH)
Doctor E. de Azambuja (Brussels, BE)
Doctor H. van der Pal (Utrecht, NL)
Doctor A. Arnold (Fort Myers, US)
Needs assessment and expected educational outcome
To refine CV monitoring strategies specifically for cancer survivors in order to deal with increasing morbidity and mortality due to premature cardiovascular disease caused by cardiotoxic cancer treatments. This webinar will also delve into serious cardiovascular complications in adult survivors of childhood cancer, as well as traditional, pre-existing CV risk factors such as hypertension, dyslipidemia and diabetes.
After watching this webinar, participants will understand:
how to organise cancer survivorship programmes, including at the local level;
strategies to improve CV health for cancer survivors; and
how to optimise long-term monitoring protocols for cancer survivors.
Cardiovascular Disease in Special Populations
Ischemic heart disease
This webinar is designed for electrophysiologists but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).